NORD’s COVID-19 Vaccines Update Webinar

FDA and CDC Leaders Address the Rare Disease Community

January 15, 2021

NORD, in collaboration with the Muscular Dystrophy Association, Cystic Fibrosis Foundation, and The ALS Association, present a special webinar that will host leaders from the Centers for Disease Control (CDC) and US Food and Drug Administration (FDA) in order to talk to the rare disease community about the COVID-19 vaccines. So far vaccines from Pfizer and Moderna have been granted the FDA’s Emergency Use Authorization.

To register, click here.